NLA Home Page
Membership
Education &
Training
Practice Tools
Networking
Opportunities
Our mission is to enhance the practice of lipid management in clinical medicine
News
May 18, 2019
Interim Results of The Medicines Company’s ORION-3 Study of Inclisiran Presented at NLA Scientific Sessions
Interim results from the ongoing ORION-3 study that examines the long-term safety and efficacy of small interfering RNA...
Read More...May 18, 2019
Encore Presentation of Landmark REDUCE-IT™ CVOT Featured at NLA Scientific Sessions
An encore presentation of the landmark cardiovascular outcomes trial REDUCE-IT™ (Reduction of Cardiovascular Events...
Read More...May 18, 2019
Statin Use Survey Among the First to Highlight Importance of Adverse Patient Experiences in Discontinuing Medication Use
MIAMI, Fla. – (May 18, 2019) – Findings of the first patient statin use survey based on a comprehensive set of patient...
Read More...